Get the Daily Brief
Latest Biotech News
AI and Computational Platforms Accelerate Drug Discovery and Target Identification
Cutting-edge AI-driven models and computational tools are enhancing drug target identification and nanoparticle characterization. OutSee’s Nomaly platform applies structural and functional genomic...
Regulatory Dynamics and Industry Leadership in Biotech
The evolving regulatory landscape and executive movements shape biotech’s strategic prospects. BioCentury reports FDA commissioner Marty Makary's controversial intervention attempt in KalVista’s...
Clinical and Translational Research Advancements
Several clinical research breakthroughs highlight progress against difficult diseases. St. Jude researchers characterized how B-cell developmental stages influence pediatric leukemia treatment...
Breakthroughs in Biomanufacturing and Clinical Facility Expansion
German contract development and manufacturing organization Vetter launched construction of a $285 million clinical manufacturing site in Des Plaines, Illinois, expanding aseptic drug production...
Genetic and Molecular Insights into Cancer and Aging
Recent studies uncover molecular mechanisms influencing cancer and aging. University of Michigan’s Rogel Cancer Center revealed how distinct classes of FOXA1 mutations drive prostate cancer...
Environmental and Ecological Biotech Innovations
Environmental research integrates biotechnology to address ecological challenges. Studies reveal groundwater’s pivotal role in sustaining coral reef chemistry and biology, highlighting...
Calico’s $596M Deal for Mabwell's Anti-Aging Therapeutics
Alphabet's Calico Life Sciences has secured exclusive global rights, barring greater China, to Mabwell Bioscience's IL-11 targeted monoclonal antibody 9MW3811, an investigational asset intended...
FDA Eases Access to CAR-T Cell Therapies
The FDA has removed the Risk Evaluation and Mitigation Strategies (REMS) for approved CAR-T therapies targeting BCMA and CD19 antigens, streamlining safety monitoring protocols established since...
Vor Bio Transitions to Autoimmune Therapy Platform
Vor Biopharma has pivoted from oncology to autoimmune disease, licensing global rights for telitacicept—a fusion protein targeting BAFF and APRIL cytokines—approved in China and in Phase 3...
Novel Codon Expansion Technique Enables Precise Protein Engineering
Researchers at Peking University have developed an innovative RNA codon expansion platform that incorporates pseudouridine-modified codons into mammalian messenger RNA, circumventing challenges of...
AI Model Predicts Chemotherapy Response in Lung Cancer
Scientists at the First Affiliated Hospital of Guangzhou Medical University have unveiled NeoPred, a novel AI framework integrating dual-phase CT imaging and clinical data to non-invasively...
Breakthroughs in Mammalian Tissue Regeneration via Genetic Switch Activation
A research team led by Wei Wang has demonstrated that activating the Aldh1a2 gene involved in vitamin A metabolism reinitiates regenerative capacity for ear tissue in mice. This evolutionary...
New Genetic Regulator Shapes Early Embryo Development
Investigators at the MRC Laboratory of Medical Sciences identified a DNA-based attenuator element that precisely modulates the temporal expression of the critical developmental gene Cdx2 during...
New Insights into Leukemia Cell Origins Improve Treatment Prospects
Research led by St. Jude Children's Research Hospital, integrating single-cell sequencing with human hematopoietic atlases, reveals that pediatric B-cell acute lymphoblastic leukemia (B-ALL)...
Clinical Manufacturing Expansion: Vetter Breaks Ground in Illinois
Contract development and manufacturing organization Vetter initiated construction of a $285 million, 160,000-square-foot clinical manufacturing facility in Des Plaines, Illinois, aiming for full...
Breakthroughs in Molecular Cancer Detection and Early Diagnostics
Wholomics, a startup originating from Dana Farber and University College London, has introduced a metabolomics-based platform utilizing nuclear magnetic resonance to detect multi-cancer signatures...
FDA Eases CAR-T Therapy Restrictions – Patient Access Could Improve
The FDA has removed several regulatory constraints for Chimeric Antigen Receptor (CAR) T-cell therapies, eliminating the requirement for Risk Evaluation and Mitigation Strategies (REMS). This...
Alphabet’s Calico Secures $596M Deal for Mabwell’s IL-11 Anti-Aging Therapeutic
Calico Life Sciences, a longevity-focused biotech affiliated with Alphabet, has entered into a licensing agreement valued at up to $596 million with Chinese company Mabwell Bioscience. The deal...
New Clinical and Scientific Insights Into Aging and Disease
Recent studies reveal pivotal mechanisms linking aging to disease development and therapeutic strategies. Notably, research highlights the role of hematopoietic stem cell mutations in blood aging...
Advancements in Cancer Diagnostics and Therapeutics
Multiple innovative approaches in oncology aim to improve patient outcomes. Wholomics has developed a metabolomics platform enabling multi-cancer detection via serum analysis, providing enhanced...